EIP
EXAS

Ellis Investment Partners’s Exact Sciences EXAS Stock Holding History

Ellis Investment Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-385
Closed -$12K – 370
2022
Q3 		$12K Buy
385
+20
+5% +$825 ﹤0.01% 537
2022
Q2 		$14K Buy
365
+65
+22% +$3.48K ﹤0.01% 535
2022
Q1 		$20K Hold
300
– – ﹤0.01% 525
2021
Q4 		$23K Buy
300
+117
+64% +$10.3K 0.01% 520
2021
Q3 		$17K Buy
183
+10
+6% +$1.06K ﹤0.01% 535
2021
Q2 		$21K Buy
173
+96
+125% +$11.5K 0.01% 504
2021
Q1 		$10K Buy
+77
New +$10.5K ﹤0.01% 579

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Ellis Investment Partners's EXAS Position: Q4 2022 in Review

Ellis Investment Partners sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 385 shares — an estimated $12K sold.

Ellis Investment Partners first reported a position in EXAS in Q1 2021 and held it in 7 quarters. The position peaked at $23K in Q4 2021. 552 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Ellis Investment Partners reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 385 Exact Sciences shares in Q4 2022, an estimated $12K.
  • Ellis Investment Partners first reported a position in Exact Sciences in Q1 2021 and held it in 7 quarters.
  • Ellis Investment Partners's Exact Sciences position peaked at $23K in Q4 2021.
  • 552 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.